Trials / Completed
CompletedNCT01568021
Post Market Surveillance of OZURDEX® for Branch Retinal Vein Occlusion (BRVO) and Central Retinal Vein Occlusion (CRVO)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (actual)
- Sponsor
- Allergan · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This multicenter observational study will assess the efficacy and tolerability of OZURDEX® in clinical practice, and will assess the time at which patients are considered for retreatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No Intervention | No intervention was administered in this study. |
Timeline
- Start date
- 2011-10-01
- Primary completion
- 2013-11-01
- Completion
- 2013-11-01
- First posted
- 2012-04-02
- Last updated
- 2015-02-10
- Results posted
- 2015-02-10
Locations
3 sites across 3 countries: Denmark, Norway, Sweden
Source: ClinicalTrials.gov record NCT01568021. Inclusion in this directory is not an endorsement.